Table 2.

Correlation Coefficients Between Different Viral Biomarkers in 96 Patients Receiving Antiviral Prophylaxis

pgRNA, log10 copies/mLHBcrAg, log10 U/mLHBsAg, log10 IU/mLHBeAg, log10 PEIU/mL
Baseline (n = 96)
 HBV DNA, log10 IU/mL0.353 (P < .000)0.324 (P = .001)0.314 (P = .002)0.207 (P = .043)
 pgRNA, log10 copies/mL0.523 (P < .000)0.456 (P < .000)0.259 (P = .011)
 HBcrAg, log10 U/mL0.490 (P < .000)0.513 (P < .000)
 HBsAg, log10 IU/mL0.538 (P < .000)
Near delivery (n = 96)
 HBV DNA, log10 IU/mL0.300 (P = .003)0.182 (P = .076)0.374 (P < .000)0.263 (P = .010)
 pgRNA, log10 copies/mL0.652 (P < .000)0.581 (P < .000)0.471 (P < .000)
 HBcrAg, log10 U/mL0.475 (P < .000)0.660 (P < .000)
 HBsAg, log10 IU/mL0.583 (P < .000)
Postpartum (n = 39)
 HBV DNA, log10 IU/mL0.332 (P = .039)0.173 (P = .291)0.332 (P = .039)0.332 (P = .039)
 pgRNA, log10 copies/mL0.799 (P < .000)0.810 (P < .000)0.636 (P < .000)
 HBcrAg, log10 U/mL0.627 (P < .000)0.739 (P < .000)
 HBsAg, log10 IU/mL0.627 (P < .000)
pgRNA, log10 copies/mLHBcrAg, log10 U/mLHBsAg, log10 IU/mLHBeAg, log10 PEIU/mL
Baseline (n = 96)
 HBV DNA, log10 IU/mL0.353 (P < .000)0.324 (P = .001)0.314 (P = .002)0.207 (P = .043)
 pgRNA, log10 copies/mL0.523 (P < .000)0.456 (P < .000)0.259 (P = .011)
 HBcrAg, log10 U/mL0.490 (P < .000)0.513 (P < .000)
 HBsAg, log10 IU/mL0.538 (P < .000)
Near delivery (n = 96)
 HBV DNA, log10 IU/mL0.300 (P = .003)0.182 (P = .076)0.374 (P < .000)0.263 (P = .010)
 pgRNA, log10 copies/mL0.652 (P < .000)0.581 (P < .000)0.471 (P < .000)
 HBcrAg, log10 U/mL0.475 (P < .000)0.660 (P < .000)
 HBsAg, log10 IU/mL0.583 (P < .000)
Postpartum (n = 39)
 HBV DNA, log10 IU/mL0.332 (P = .039)0.173 (P = .291)0.332 (P = .039)0.332 (P = .039)
 pgRNA, log10 copies/mL0.799 (P < .000)0.810 (P < .000)0.636 (P < .000)
 HBcrAg, log10 U/mL0.627 (P < .000)0.739 (P < .000)
 HBsAg, log10 IU/mL0.627 (P < .000)

Correlation coefficients were calculated by Spearman's test; P = P value of correlation t test.

Abbreviations: HBcrAg, hepatitis B core-related antigen; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; pgRNA, pregenomic RNA.

Table 2.

Correlation Coefficients Between Different Viral Biomarkers in 96 Patients Receiving Antiviral Prophylaxis

pgRNA, log10 copies/mLHBcrAg, log10 U/mLHBsAg, log10 IU/mLHBeAg, log10 PEIU/mL
Baseline (n = 96)
 HBV DNA, log10 IU/mL0.353 (P < .000)0.324 (P = .001)0.314 (P = .002)0.207 (P = .043)
 pgRNA, log10 copies/mL0.523 (P < .000)0.456 (P < .000)0.259 (P = .011)
 HBcrAg, log10 U/mL0.490 (P < .000)0.513 (P < .000)
 HBsAg, log10 IU/mL0.538 (P < .000)
Near delivery (n = 96)
 HBV DNA, log10 IU/mL0.300 (P = .003)0.182 (P = .076)0.374 (P < .000)0.263 (P = .010)
 pgRNA, log10 copies/mL0.652 (P < .000)0.581 (P < .000)0.471 (P < .000)
 HBcrAg, log10 U/mL0.475 (P < .000)0.660 (P < .000)
 HBsAg, log10 IU/mL0.583 (P < .000)
Postpartum (n = 39)
 HBV DNA, log10 IU/mL0.332 (P = .039)0.173 (P = .291)0.332 (P = .039)0.332 (P = .039)
 pgRNA, log10 copies/mL0.799 (P < .000)0.810 (P < .000)0.636 (P < .000)
 HBcrAg, log10 U/mL0.627 (P < .000)0.739 (P < .000)
 HBsAg, log10 IU/mL0.627 (P < .000)
pgRNA, log10 copies/mLHBcrAg, log10 U/mLHBsAg, log10 IU/mLHBeAg, log10 PEIU/mL
Baseline (n = 96)
 HBV DNA, log10 IU/mL0.353 (P < .000)0.324 (P = .001)0.314 (P = .002)0.207 (P = .043)
 pgRNA, log10 copies/mL0.523 (P < .000)0.456 (P < .000)0.259 (P = .011)
 HBcrAg, log10 U/mL0.490 (P < .000)0.513 (P < .000)
 HBsAg, log10 IU/mL0.538 (P < .000)
Near delivery (n = 96)
 HBV DNA, log10 IU/mL0.300 (P = .003)0.182 (P = .076)0.374 (P < .000)0.263 (P = .010)
 pgRNA, log10 copies/mL0.652 (P < .000)0.581 (P < .000)0.471 (P < .000)
 HBcrAg, log10 U/mL0.475 (P < .000)0.660 (P < .000)
 HBsAg, log10 IU/mL0.583 (P < .000)
Postpartum (n = 39)
 HBV DNA, log10 IU/mL0.332 (P = .039)0.173 (P = .291)0.332 (P = .039)0.332 (P = .039)
 pgRNA, log10 copies/mL0.799 (P < .000)0.810 (P < .000)0.636 (P < .000)
 HBcrAg, log10 U/mL0.627 (P < .000)0.739 (P < .000)
 HBsAg, log10 IU/mL0.627 (P < .000)

Correlation coefficients were calculated by Spearman's test; P = P value of correlation t test.

Abbreviations: HBcrAg, hepatitis B core-related antigen; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; pgRNA, pregenomic RNA.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close